Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with advanced or metastatic non-small cell lung cancer (a type of lung cancer that has spread or is at a late stage).
• You are at least 18 years old on the day you sign the consent form to join the study.
• You are willing and able to sign a consent form agreeing to take part in the study.
• You are eligible to receive certain types of cancer treatments, either approved or not yet fully approved by the FDA — including specific immunotherapy drugs (such as pembrolizumab, nivolumab, atezolizumab, or durvalumab), used alone or combined with chemotherapy, OR certain targeted therapy drugs called tyrosine kinase inhibitors.
• You will be officially enrolled in the study once your biological samples have been submitted, with your registration date being the date of the last sample submitted (confirm with trial site).

Who may not be able to join:

• You may not be able to join if your doctor or the lead researcher decides that your health condition is too unstable for you to safely participate in the study, and they may advise you to focus on your current treatment instead.

Important: Always verify eligibility with the trial site directly before applying.